PerClot to Control Bleeding in Endoscopic Sinus Surgery

Completed

• Conditions: Sinusitis

• Registration Number: NCT02221128
• Lead Sponsor: CryoLife Europa

Brief Summary

A prospective, single centre, single arm study designed to collect clinical data on PerClot when used in subjects undergoing endoscopic sinus surgery.

Detailed Description

Not available

Study Timeline

• Status Verified: 2014-07
• Study Start: 2014-07
• Study First Submitted: 2014-07-03
• Study First Submitted QC: 2014-08-19
• Study First Posted: 2014-08-20
• Primary Completion: 2014-09
• Study Completion: 2014-09
• Last Update Submitted: 2014-10-02
• Last Update Posted: 2014-10-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

• Subjects having Endoscopic Sinus Surgery
• Subjects who will have PerClot used as a haemostatic agent
• Subjects willing and able to give consent
• Subjects over 18 years old

Exclusion Criteria

• Subjects unable or unwilling to give consent for their data to be collected

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of subjects who achieve of haemostasis after the application of PerClot	intraoperatively

Secondary Outcome Measures

Name	Time	Method
Number of subjects who require the use of alternative methods to achieve haemostasis after the application of PerClot	intraoperatively

Trial Locations

Locations (1)

Guys and St Thomas NHS Trust; 🇬🇧 London, United Kingdom